Crystal Structures of Ral-GppNHp and Ral-GDP Reveal Two Binding Sites that Are Also Present in Ras and Rap

Department of Molecular and Structural Biochemistry, 128 Polk Hall-CB 7622, North Carolina State University, Raleigh, NC 27695, USA.
Structure (Impact Factor: 5.62). 12/2004; 12(11):2025-36. DOI: 10.1016/j.str.2004.08.011
Source: PubMed


RalA is a GTPase with effectors such as Sec5 and Exo84 in the exocyst complex and RalBP1, a GAP for Rho proteins. We report the crystal structures of Ral-GppNHp and Ral-GDP. Disordered switch I and switch II, located away from crystal contacts, are observed in one of the molecules in the asymmetric unit of the Ral-GppNHp structure. In the other molecule in the asymmetric unit, a second Mg(2+) ion is bound to the GppNHp gamma-phosphate in an environment in which switch I is pulled away from the nucleotide and switch II is found in a tight beta turn. Clustering of conserved residues on the surface of Ral-GppNHp identifies two putative sites for protein-protein interaction. One site is adjacent to switch I. The other is modulated by switch II and is obstructed in Ral-GDP. The Ral structures are discussed in the context of the published structures of the Ral/Sec5 complex, Ras, and Rap.

Download full-text


Available from: Nathan Nicely, Jun 26, 2014
  • Source
    • "Like Ras, Ral proteins cycle between inactive GDP-bound and active GTP-bound states (Fig. 2A). RalA and RalB share complete sequence identity in the switch I (SI) and II (SII) sequences that change conformation during GDP–GTP cycling [8] (Fig. 1D). As described below, SI and SII are involved in recognition by both regulators and effectors. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Since their discovery in 1986, Ral (Ras-like) GTPases have emerged as critical regulators of diverse cellular functions. Ral-selective guanine nucleotide exchange factors (RalGEFs) function as downstream effectors of the Ras oncoprotein, and the RalGEF-Ral signaling network comprises the third best characterized effector of Ras-dependent human oncogenesis. Because of this, Ral GTPases as well as their effectors are being explored as possible therapeutic targets in the treatment of RAS mutant cancer. The two Ral isoforms, RalA and RalB, interact with a variety of downstream effectors and have been found to play key and distinct roles in both normal and neoplastic cell physiology including regulation of vesicular trafficking, migration and invasion, tumor formation, metastasis, and gene expression. In this review we provide an overview of Ral biochemistry and biology, and we highlight recent discoveries.
    Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 09/2014; 1843(12). DOI:10.1016/j.bbamcr.2014.09.004 · 5.02 Impact Factor
  • Source
    • "The experiment shows three blots from the same pull-down experiment and results are representative of at least three independent experiments for each construct. (B) Crystal structure of GDP-bound RalA [55], indicating the switch I (cyan) and switch II (red) regions and the residues mutated for pull-down assays. (Pdb code: 1U90). "
    [Show abstract] [Hide abstract]
    ABSTRACT: RalA is a membrane-associated small GTPase that regulates vesicle trafficking. Here we identify a specific interaction between RalA and ERp57, an oxidoreductase and signalling protein. ERp57 bound specifically to the GDP-bound form of RalA, but not the GTP-bound form, and inhibited the dissociation of GDP from RalA in vitro. These activities were inhibited by reducing agents, but no disulphide bonds were detected between RalA and ERp57. Mutation of all four of ERp57's active site cysteine residues blocked sensitivity to reducing agents, suggesting that redox-dependent conformational changes in ERp57 affect binding to RalA. Mutations in the switch II region of the GTPase domain of RalA specifically reduced or abolished binding to ERp57, but did not block GTP-specific binding to known RalA effectors, the exocyst and RalBP1. Oxidative treatment of A431 cells with H(2)O(2) inhibited cellular RalA activity, and the effect was exacerbated by expression of recombinant ERp57. The oxidative treatment significantly increased the amount of RalA localised to the cytosol. These findings suggest that ERp57 regulates RalA signalling by acting as a redox-sensitive guanine-nucleotide dissociation inhibitor (RalGDI).
    PLoS ONE 11/2012; 7(11):e50879. DOI:10.1371/journal.pone.0050879 · 3.23 Impact Factor
  • Source
    • "Exo84p does interact with Sec5p and/or Sec10p [27], proteins that we were not able to identify with confidence in our data. Exo84p can also interact with Ras and Ral GTPase proteins similar to Rab3a [30] "
    [Show abstract] [Hide abstract]
    ABSTRACT: Metallothionein 3 (MT-3), also known as growth inhibitory factor (GIF), exhibits a neuroinhibitory activity. Our lab and others have previously shown that this biological activity involves interacting protein partners in the brain. However, nothing specific is yet known about which of these interactions is responsible for the GIF activity. In this paper, we are reporting upon new proteins found interacting with MT-3 as determined through immunoaffinity chromatography and mass spectrometry. These new partner proteins—Exo84p, 14-3-3 Zeta, α and β Enolase, Aldolase C, Malate dehydrogenase, ATP synthase, and Pyruvate kinase—along with those previously identified have now been classified into three functional groups: transport and signaling, chaperoning and scaffolding, and glycolytic metabolism. When viewed together, these interactions support a proposed model for the regulation of the GIF activity of MT-3.
    International Journal of Alzheimer's Disease 12/2010; 2011(3):208634. DOI:10.4061/2011/208634
Show more